UNASSIGNED: This retrospective study included a total of 180 patients. These patients were categorized into two groups: the lidocaine group, which received 2% lidocaine (1:100,000 adrenaline), and the articaine group, which received 4% articaine (1:100,000 adrenaline) for local anesthesia. The study compared anesthesia efficacy, intraoperative pain levels, intraoperative bleeding, as well as differences in heart rate and blood pressure between the two groups.
UNASSIGNED: The articaine group demonstrated a significantly lower visual analog scale (VAS) pain score when compared to the lidocaine group, measuring at 4.4 ± 0.6 cm vs. 5.0 ± 1.0 cm, respectively (P < 0.0001). Additionally, the articaine group exhibited a higher anesthesia efficacy compared to the lidocaine group (89.0% vs. 76.6%, p = 0.0487). Notably, the articaine group experienced less nasal mucosal bleeding during the surgery in contrast to the lidocaine group (p = 0.004). However, there were no statistically significant differences in changes in blood pressure and heart rate between the two groups (p > 0.05).
UNASSIGNED: This study demonstrated that 4% articaine (1:100,000 adrenaline) has superior clinical effectiveness in comparison to 2% lidocaine (1:100,000 adrenaline) in EN-DCR.
■这项回顾性研究共包括180名患者。这些患者分为两组:利多卡因组,接受2%利多卡因(1:100,000肾上腺素),阿替卡因组,接受4%阿替卡因(1:100,000肾上腺素)局部麻醉。该研究比较了麻醉效果,术中疼痛水平,术中出血,以及两组之间心率和血压的差异。
■阿替卡因组与利多卡因组相比,显示出明显较低的视觉模拟评分(VAS)疼痛评分,测量在4.4±0.6厘米与5.0±1.0cm,分别为(P<0.0001)。此外,与利多卡因组相比,阿替卡因组表现出更高的麻醉效果(89.0%vs.76.6%,p=0.0487)。值得注意的是,与利多卡因组相比,阿替卡因组手术期间鼻粘膜出血较少(p=0.004).然而,两组患者血压、心率变化差异无统计学意义(p>0.05)。
■这项研究表明,与EN-DCR中的2%利多卡因(1:100,000肾上腺素)相比,4%阿替卡因(1:100,000肾上腺素)具有更好的临床疗效。